Management Therapy of ST-Segment Elevation Myocardial Infarction: A Literature Review

Irma Novrianti, Dhani Wijaya, Faizal Mustamin, Sari Wijayanti

Abstract


Coronary Heart Disease (CHD) is the cardiovascular disease due to plaque build-up in the coronary artery, reducing the blood follow to the heart. STEMI (ST-segment elevation myocardial infarction) is the CHD due to the ST-segment elevation in 12 and the cardiac marker elevation as Troponin I. The elevation is due to a blockage in the coronary artery, causing the blood perfusion and oxygen supply for the heart to decrease. The objective of the article review is to describe the correct STEMI therapy based on the research findings and references listed in the literary review. This review was made with the study of literature published in 1993-2019. Conclusion: STEMI therapy management is discomfort management and reperfusion therapy. The reperfusion therapy is aimed to recover the myocardial blood flow, to heal the heart, and to reduce the mortality level. The primary coronary artery reperfusion can be administered with the primary percutaneous coronary intervention (PCI). PCI can open a blockage in the coronary artery and has a good effect on the short-term and long-term clinical results. Besides, it reduces the death risk, myocardial infarction, or repetitive stroke. Meanwhile, reperfusion using fibrinolytics is conducted when PCI is unavailable. Moreover, anticoagulant, antithrombotic, and vasodilators are supporting therapies for STEMI patients to reduce chest pain and prevent reinfarction

Full Text:

PDF

References


Kemenkes R. Kementrian Kesehatan Republik Indonesia. [Online].; 2017 [cited 2018 July 28. Available from: www.depkes.go.id.

Kemenkes. Hasil Utama Riskesda 2018. Jakarta: Kementrian Kesehatan Republik Indonesia; 2018.

Tumade B, Jim EL, Joseph VF. Prevalensi sindrom koroner akut di RSUP Prof. Dr. R. D. Kandou Manado periode 1 Januari 2014 – 31 Desember 2014. Jurnal e-Clinic (eCl). 2016; 4(1): p. 223-230.

Roger V, wita , sari , yani. Heart disease and stroke statistics 2011 update : A report from the American Heart Association. Circulation. 2011; 123: p. e18-e209.

Anwar S, Eni k, Asni Z, Malik I. Histopatologi Arteri Koroner Rattus novergicus Strain Wistar Jantan Pada Minggu Ke-12 Setelah Pemberian Diet Aterogenik. Jom FK. 2014 Oktober; 1(2)

Stephen J, Stephen L, Jitendra S, Tiong O, Chee TC, Hyo-Soo K, et al. Catastrophic health expenditure on acute coronary events in Asia: a prospective study. Bulletin of the World Health Organization. 2016; 94: p. 193-200.

Dipiro J, Talbert RL, Yee GC, Maizke GA, Wells Barbara G, Posey M. Acute Coronary Syndrome. In Pharmacotherapy: A Pathophysiologic Approach. 8th ed. United States: McGraw-Hill Education; 2009. p. 642-575.

Antman E, Loscalzo J. ST-Segment Elevation Myocardial Infarction. In D LK, editor. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw-Hill Education; 2015. p. 1599-1611.

Sampson AJ, Paul T, Stouffer GA. Pharmacological Therapy in The Management of Acute Coronary Syndromes. In Wang H, Patterson C, editors. Atherosclerosis: Risks, Mechanisms, and Therapies. First Edition ed. NC, USA: John Wiley & Sons, Inc; 2015. p. 517-531.

Daga LC, Kaul U, Mansoor A. Approach to STEMI and NSTEMI. SUPPLEMENT TO JAPI • decem ber 2011 • VOL. 59. 2011; 59: p. 19-25.

Newby DE, Grubb NR, Bradbury A. Cardiovascular Disease. In Colledge NR, Walker BR, Ralston BH, editors. Davidson's Principle and Practice of Medicine. 21st ed. Edinburgh: Elsevier; 2010. p. 577-598.

Antman EM, Loscalzo J. ST-Segment Elevation Myocardial Infarction. In D LK, editor. Harrison's Principles of Internal Medicine. 19th ed. New York : McGraw-Hill Education; 2015. p. pp. 1599-1611.

Ibanez B, Stefan J, Stefan A, He´ctor B, Christoph V, Pascal V. 2017 ESC Guidelines for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2018; 39: p. 119-177.

Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson LJ, Loscalzo J. ST-Segmen Elevation Miocardial Infarction. In Harrison's Manual Of Medicine. 19th ed. New York: McGraw-Hill Education; 2016. p. 658-667.

Duarte GS, Afonso NF, Filipe BR, Fausto JP, Joaquim JF, Joao C, et al. Morphine in acute coronary syndrome: systematic review and meta-analysis. BMJ Open. 2019 January; 9.

Fox K, White HD, Gersh B, Opie LH. Antithrombotic Agents: Platelet Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In Drugs For The Heart. Eighth Edition ed. Philadelphia: Saunders Elsevier Inc; 2013. p. 378-387.

Indonesia PDSK. Pedoman Penatalaksanaan SIndrom Koroner Akut. Jurnal Kardiologi Indonesia. 2015.

Hendersoni M, Carberry J, Colin B. Targeting an Ischemic Time >

Ibanez B, Stefan J, Stefan A, Manuel A, Bucciarelli-Ducci C, He´ctor B. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. 2018; 39: p. 119-177.

The GUSTO I. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Eng J Med. 1993; 329(10): p. 673– 682.

Ghaffar S, Kazemi B, Golzari IG. Ghaffari, S., KazemEfficacy of a New Accelerated Streptokinase Regime in Acute Myocardial Infarction: A Double Blind Randomized Clinical Trial. 2011. Cardiovascular Therapeutics, pp.1-7.; 00.

Jinatongthai P, unporn K, Chee YF, Arintaya P, Surakit N, Ammarin T, et al. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis. Lancet. 2017 Agustus; 390.

Vivek L. Fibrinolytic Drug Therapy in the Management of Intravascular Thrombosis, Especially Acute Myocardial Infarction - A Review. J of Pharmacol & Clin Res. 2017; 2(4): p. 001-005.

Sekhar GR, Ramya N, Poojitha G, Bhargavi C, Madhuri R. A Review on Thrombolytic Therapy used in Myocardial Infarction (Streptokinase vs Tenecteplase). Int. J. Pharm. Sci. Rev. Res. 2017; 45(2): p. 29-32.

Antmann E, Braunwald E, Loscalzo J. ST Segment Eelevation Myocardial Infarction. In Harisson’s Cardiovascular Medicine. New york: Mc Graw Hill Inc; 2010.

Lim SH, wee J, Anantharaman V. Management of STEMI. Curr Emerg Hosp Med Rep. 2013; 1: p. 29–36.

Mega JL, Morrow DA. ST-Elevation Myocardial Infarction: Management. In Braunwald's Heart Disease: A Textbook of Cardiovascular. Tenth Edition ed. Philadelphia: Saunders Elsevier Inc; 2015. p. 1095-1142..




DOI: https://doi.org/10.18860/jip.v5i2.8989

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Irma Novrianti, Dhani wijaya



© 2023 Journal of Islamic Pharmacy